Convective-controlled double high flux hemodiafiltration: A novel blood purification modality

International Journal of Artificial Organs

Volumn 27, Issue 3, 2004, Pages 195-204

  Pisitkun, T ^a   Eiam Ong, Somchai ^a   Tiranathanagul, K ^a   Sakunsrijinda, C ^a   Manotham, K ^a   Hanvivatvong, O ^b   Suntaranuson, P ^b   Praditpornsilpa, K ^a   Chusil, S ^a   Tungsanga, K ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Convective therapy; Double high flux hemodiafiltration; 2 microglobulin

Indexed keywords

DIALYSIS; PATIENT TREATMENT;

BLOOD PURIFICATION; CONVECTIVE THERAPY; DOUBLE HIGH FLUX HEMODIAFILTRATION; HAEMODIALYSIS; HEMODIAFILTRATION; HIGH FLUX; PERFORMANCE; QUALITY OF LIFE; SS2-MICROGLOBULIN;

HEMODIALYZERS;

BETA 2 MICROGLOBULIN; BICARBONATE; CALCITRIOL; CALCIUM CARBONATE; DIALYSIS FLUID; ERYTHROPOIETIN; HEPARIN; IRON; SUCROSE; UREA;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; REFERENCE VALUE; THAILAND; THERMODYNAMICS;

EID: 2342565017     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700306     Document Type: Article

References (16)

1. USRDS: The United States Renal Data System. Am J Kidney Dis 2003; 42 (suppl 5): S1-230.
2. Canaud B, Leray-Moragues H, Bosc JY, Leblanc M. Ultrafiltration and convective-based dialysis modalities: New trends and applications for renal replacement therapy in ESRD patients. Nephrol Dial Transplant 1999; 14 (suppl 3): S98-105.
3. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Cossu M, Ferrara R, Ganadu M, Cadinu F, Serra G, Cabiddu G, Sau G, Casu D, Passaghe M, Bolasco F, Pistis R, Ghisu T. Second Sardinian Multicentre Study. Predilution haemofiltration-the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant 2001; 16: 1207-13.
4. Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, Mion C. On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000; 15 (suppl 1): S60-7.
5. von Albertini B, Barlee V, Bosch JP. Double high-flux-hemodiafiltration: A means to enhance efficiency and efficacy of dialysis (Abstract). J Am Soc Nephrol 1996; 7: 1423.
6. Barlee V, Vassalotti JA, Valesquez MT, Lew SQ, Mishkin GJ, Bosch JP. Comparison of small and large molecular weight solute clearance with three different methods of hemodiafiltration (Abstract). J Am Soc Nephrol 1999; 10: 188.
7. Grant ME, Lovell HB, Wiegmann TB. Current use of anticoagulation in hemodialysis. Semin Dial 1991; 4: 168-73.
8. Depner TA, Keshaviah PR, Ebben JP, Emerson PF, Collins AJ, Jindal KK, Nissenson AR, Lazarus JM, Pu K. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 1996; 7: 464-71.
9. Hays RD, Kallich JD, Mapes DL, Coons SJ, Amin N, Carter WB. Kidney Disease Quality of Life Short Form (KDQOL-SFTM), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: RAND, P-7994.
10. Pohlmeier R, Vienken J. Phosphate removal and hemodialysis conditions. Kidney Int 2001; 59 (suppl 78): S190-4.
11. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000; 11: 2344-50.
12. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, Port FK. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999; 33: 349-55.
13. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997; 52: 1096-101.
14. Cappelli G, Perrone S, Ciuffreda A. Water quality for on-line haemodiafiltration. Nephrol Dial Transplant 1998; 13 (suppl 5): S12-6.
15. Ward RA. Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis. Semin Dial 2000; 13: 378-80.
16. Wiesholzer M, Harm F, Hauser AC, Pribasnig A, Balcke P. Inappropriately high plasma leptin levels in obese haemodialysis patients can be reduced by high flux haemodialysis and haemodiafiltration. Clin Sci (Lond) 1998; 94: 431-5.